This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hudson, J B Articles by Laiminis, L A Search for Related Content PubMed PubMed Citation Articles by Hudson, J B Articles by Laiminis, L A

Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18.

Howard Hughes Medical Institute, Chicago, Illinois.

ABSTRACT

The E6-E7 region of human papillomavirus types 16 and 18 is selectively retained and expressed in cervical carcinoma cells. In cultured human keratinocytes, expression of the E6 and E7 open reading frames of human papillomavirus type 18, under the control of its homologous promoter, resulted in high-frequency immortalization. Furthermore, by using a system that allows for stratification of keratinocytes in vitro (raft system), we observed that the morphological differentiation of these E6-E7 immortalized cells was altered such that parabasal cells extended throughout most of the epithelium, with abnormal nuclei present in the upper regions. Examination of E6-E7-expressing cell lines in the raft system at a later passage revealed that complete loss of morphological differentiation had occurred. E7 alone was a much less effective immortalizing agent than E6 and E7 together and acted only minimally to alter morphological differentiation in vitro. No such activities were found for E6 alone. High-frequency transformation of human epithelial cells thus appears to require expression of both E6 and E7 gene products.

This article has been cited by other articles:

• Zheng, L., Ding, H., Lu, Z., Li, Y., Pan, Y., Ning, T., Ke, Y. (2008). E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6.. GENES CELLS 13: 285-294 [Abstract] [Full Text]  
• Ressler, S., Scheiden, R., Dreier, K., Laich, A., Muller-Holzner, E., Pircher, H., Morandell, D., Stein, I., Viertler, H.-P., Santer, F. R., Widschwendter, A., Even, J., Jansen-Durr, P., Capesius, C., Zwerschke, W. (2007). High-risk Human Papillomavirus E7 Oncoprotein Detection in Cervical Squamous Cell Carcinoma. Clin. Cancer Res. 13: 7067-7072 [Abstract] [Full Text]  
• Storrs, C. H., Silverstein, S. J. (2007). PATJ, a Tight Junction-Associated PDZ Protein, Is a Novel Degradation Target of High-Risk Human Papillomavirus E6 and the Alternatively Spliced Isoform 18 E6. J. Virol. 81: 4080-4090 [Abstract] [Full Text]  
• BORUTINSKAITE, V. V., NAVAKAUSKIENE, R., MAGNUSSON, K.-E. (2006). Retinoic Acid and Histone Deacetylase Inhibitor BML-210 Inhibit Proliferation of Human Cervical Cancer HeLa Cells. Ann. N. Y. Acad. Sci. 1091: 346-355 [Abstract] [Full Text]  
• Hiller, T., Poppelreuther, S., Stubenrauch, F., Iftner, T. (2006). Comparative Analysis of 19 Genital Human Papillomavirus Types with Regard to p53 Degradation, Immortalization, Phylogeny, and Epidemiologic Risk Classification.. Cancer Epidemiol. Biomarkers Prev. 15: 1262-1267 [Abstract] [Full Text]  
• Kraus, I., Molden, T., Holm, R., Lie, A. K., Karlsen, F., Kristensen, G. B., Skomedal, H. (2006). Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas. J. Clin. Microbiol. 44: 1310-1317 [Abstract] [Full Text]  
• Fiedler, M., Ressler, S., Campo-Fernandez, B., Laich, A., Jansen, L., Widschwendter, A., Viertler, H.-P., Bacher, N., Morandell, D., Muller-Holzner, E., Durst, M., Jansen-Durr, P., Zwerschke, W. (2005). Expression of the high-risk human papillomavirus type 18 and 45 E7 oncoproteins in cervical carcinoma biopsies. J. Gen. Virol. 86: 3235-3241 [Abstract] [Full Text]  
• Nakahara, T., Peh, W. L., Doorbar, J., Lee, D., Lambert, P. F. (2005). Human Papillomavirus Type 16 E1{wedge}E4 Contributes to Multiple Facets of the Papillomavirus Life Cycle. J. Virol. 79: 13150-13165 [Abstract] [Full Text]  
• Molden, T., Kraus, I., Karlsen, F., Skomedal, H., Nygard, J. F., Hagmar, B. (2005). Comparison of Human Papillomavirus Messenger RNA and DNA Detection: A Cross-sectional Study of 4,136 Women >30 Years of Age with a 2-Year Follow-up of High-Grade Squamous Intraepithelial Lesion. Cancer Epidemiol. Biomarkers Prev. 14: 367-372 [Abstract] [Full Text]  
• McMurray, H. R., McCance, D. J. (2004). Degradation of p53, Not Telomerase Activation, by E6 Is Required for Bypass of Crisis and Immortalization by Human Papillomavirus Type 16 E6/E7. J. Virol. 78: 5698-5706 [Abstract] [Full Text]  
• Patel, D., Incassati, A., Wang, N., McCance, D. J. (2004). Human Papillomavirus Type 16 E6 and E7 Cause Polyploidy in Human Keratinocytes and Up-Regulation of G2-M-Phase Proteins. Cancer Res. 64: 1299-1306 [Abstract] [Full Text]  
• Fu, B., Quintero, J., Baker, C. C. (2003). Keratinocyte Growth Conditions Modulate Telomerase Expression, Senescence, and Immortalization by Human Papillomavirus Type 16 E6 and E7 Oncogenes. Cancer Res. 63: 7815-7824 [Abstract] [Full Text]  
• Kaufmann, A. M., Stern, P. L., Rankin, E. M., Sommer, H., Nuessler, V., Schneider, A., Adams, M., Onon, T. S., Bauknecht, T., Wagner, U., Kroon, K., Hickling, J., Boswell, C. M., Stacey, S. N., Kitchener, H. C., Gillard, J., Wanders, J., Roberts, J. St. C., Zwierzina, H. (2002). Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in Women with Progressive Cervical Cancer. Clin. Cancer Res. 8: 3676-3685 [Abstract] [Full Text]  
• Nakahara, T., Nishimura, A., Tanaka, M., Ueno, T., Ishimoto, A., Sakai, H. (2002). Modulation of the Cell Division Cycle by Human Papillomavirus Type 18 E4. J. Virol. 76: 10914-10920 [Abstract] [Full Text]  
• Huang, S.-M., McCance, D. J. (2002). Down Regulation of the Interleukin-8 Promoter by Human Papillomavirus Type 16 E6 and E7 through Effects on CREB Binding Protein/p300 and P/CAF. J. Virol. 76: 8710-8721 [Abstract] [Full Text]  
• Nguyen, D. X., Westbrook, T. F., McCance, D. J. (2002). Human Papillomavirus Type 16 E7 Maintains Elevated Levels of the cdc25A Tyrosine Phosphatase during Deregulation of Cell Cycle Arrest. J. Virol. 76: 619-632 [Abstract] [Full Text]  
• Degenhardt, Y. Y., Silverstein, S. (2001). Interaction of Zyxin, a Focal Adhesion Protein, with the E6 Protein from Human Papillomavirus Type 6 Results in Its Nuclear Translocation. J. Virol. 75: 11791-11802 [Abstract] [Full Text]  
• Oh, S. T., Kyo, S., Laimins, L. A. (2001). Telomerase Activation by Human Papillomavirus Type 16 E6 Protein: Induction of Human Telomerase Reverse Transcriptase Expression through Myc and GC-Rich Sp1 Binding Sites. J. Virol. 75: 5559-5566 [Abstract] [Full Text]  
• Degenhardt, Y. Y., Silverstein, S. J. (2001). Gps2, a Protein Partner for Human Papillomavirus E6 Proteins. J. Virol. 75: 151-160 [Abstract] [Full Text]  
• Muderspach, L., Wilczynski, S., Roman, L., Bade, L., Felix, J., Small, L. A., Kast, W. M., Fascio, G., Marty, V., Weber, J. (2000). A Phase I Trial of a Human Papillomavirus (HPV) Peptide Vaccine for Women with High-Grade Cervical and Vulvar Intraepithelial Neoplasia Who Are HPV 16 Positive. Clin. Cancer Res. 6: 3406-3416 [Abstract] [Full Text]  
• Kao, W. H., Beaudenon, S. L., Talis, A. L., Huibregtse, J. M., Howley, P. M. (2000). Human Papillomavirus Type 16 E6 Induces Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase. J. Virol. 74: 6408-6417 [Abstract] [Full Text]  
• Crish, J. F., Bone, F., Balasubramanian, S., Zaim, T. M., Wagner, T., Yun, J., Rorke, E. A., Eckert, R. L. (2000). Suprabasal expression of the human papillomavirus type 16 oncoproteins in mouse epidermis alters expression of cell cycle regulatory proteins. Carcinogenesis 21: 1031-1037 [Abstract] [Full Text]  
• Francis, D. A., Schmid, S. I., Howley, P. M. (2000). Repression of the Integrated Papillomavirus E6/E7 Promoter Is Required for Growth Suppression of Cervical Cancer Cells. J. Virol. 74: 2679-2686 [Abstract] [Full Text]  
• Kim, K. Y., Blatt, L., Taylor, M. W. (2000). The effects of interferon on the expression of human papillomavirus oncogenes. J. Gen. Virol. 81: 695-700 [Abstract] [Full Text]  
• Smith-McCune, K., Kalman, D., Robbins, C., Shivakumar, S., Yuschenkoff, L., Bishop, J. M. (1999). Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130. Proc. Natl. Acad. Sci. USA 96: 6999-7004 [Abstract] [Full Text]  
• Ronco, L. V., Karpova, A. Y., Vidal, M., Howley, P. M. (1998). Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12: 2061-2072 [Abstract] [Full Text]  
• Chen, J. J., Hong, Y., Rustamzadeh, E., Baleja, J. D., Androphy, E. J. (1998). Identification of an alpha  Helical Motif Sufficient for Association with Papillomavirus E6. J. Biol. Chem. 273: 13537-13544 [Abstract] [Full Text]  
• Reznikoff, C A, Belair, C, Savelieva, E, Zhai, Y, Pfeifer, K, Yeager, T, Thompson, K J, DeVries, S, Bindley, C, Newton, M A (1994). Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells.. Genes Dev. 8: 2227-2240 [Abstract]  
• Pan, H, Griep, A E (1994). Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.. Genes Dev. 8: 1285-1299 [Abstract]  
• Howes, K A, Ransom, N, Papermaster, D S, Lasudry, J G, Albert, D M, Windle, J J (1994). Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53.. Genes Dev. 8: 1300-1310 [Abstract]  
• Moles, J., Schiller, J., Tesniere, A, Leigh, I., Guilhou, J., Basset-Seguin, N (1994). Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J. Cell Sci. 107: 435-441 [Abstract]  
• Dollard, S C, Wilson, J L, Demeter, L M, Bonnez, W, Reichman, R C, Broker, T R, Chow, L T (1992). Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. OFF.. Genes Dev. 6: 1131-1142 [Abstract]  
• zur Hausen, H (1991). Viruses in human cancers. Science 254: 1167-1173 [Abstract]